Maze Therapeutics (MAZE) Other Non Operating Income (2024 - 2026)

Maze Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 10.33% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 260.51% YoY), while the FY2024 annual figure was -$8.8 million, changed N/A from the prior year.
• Other Non Operating Income came in at $2.3 million for Q1 2026 at Maze Therapeutics, down from $2.6 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.6 million in Q1 2025 to a low of -$4.8 million in Q1 2024.
• A 3-year average of -$646166.7 and a median of -$714000.0 in 2024 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income surged 154.93% in 2025 and retreated 10.33% in 2026, its largest moves.
• Maze Therapeutics' Other Non Operating Income stood at -$1.6 million in 2024, then jumped by 259.06% to $2.6 million in 2025, then fell by 10.33% to $2.3 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $2.3 million, $2.6 million, and -$1.6 million for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison